<DOC>
	<DOCNO>NCT00668239</DOCNO>
	<brief_summary>This study compare use intravitreous triamcinolone laser therapy treat maculopahty patient type 2 diabetes mellitus short-tem period 6 month</brief_summary>
	<brief_title>Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone Laser</brief_title>
	<detailed_description>The purpose double blind randomize clinical trial compare treatment diffuse diabetic macular oedema intravitreal triamcinolone laser patient type 2 diabetes mellitus ( DM ) , use morphofunctional assessment . Patients clinically significant diffuse macular oedema , previously untreated macular thickness &gt; 250 Î¼m optical coherence tomography ( OCT ) randomize treatment Laser intravitreal injection Triamcinolone acetate . Optical coherence tomography ( OCT ) , biomicroscopy , fundoscopy , fluorescein angiography , tonometry , scotometry , visual acuity contrast acuity perform 0 , 1 , 3 6 month .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>patient type 2 DM , diffuse macular oedema secondary diabetic retinopathy , see Centre Reference Diabetic Retinopathy Hospital de Clinicas de Porto Alegre ( HCPA ) Ophthalmology Outpatient Clinic HCPA , patient type 2 DM previous treatment diffuse macular oedema secondary diabetic retinopathy</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>diffuse macular oedema</keyword>
	<keyword>type 2 diabetes mellitus</keyword>
	<keyword>laser therapy</keyword>
</DOC>